Literature DB >> 26025649

Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.

You-You Xia1, Li Yin2, Ning Jiang2, Wen-Jie Guo2, Hao Tian3, Xue-Song Jiang2, Jing Wu3, Meng Chen3, Jian-Zhong Wu4, Xia He5.   

Abstract

BACKGROUND: Epithelial-mesenchymal transition (EMT) is associated with invasion and metastasis of cancer cells. High-mobility group AT-hook 2 (HMGA2) has been found to play a critical role in EMT in a number of malignant tumors. However, whether HMGA2 regulates the EMT in human nasopharyngeal carcinoma (NPC) is unclear.
OBJECTIVE: The aim of this study was to investigate the effect and mechanism of HMGA2 in inducing invasion and migration in NPC.
METHODS: In NPC tissues samples, the association of HMGA2 mRNA expression with clinicopathological characteristics were estimated by real-time quantitative RT-PCR(qRT-PCR). In vitro, following the silencing of HMGA2 in CNE-1 and CNE-2 cell lines, the viability and metastatic ability were analyzed using Cell Counting Kit-8 (CCK8), colony formation assay, and transwell assay. EMT and transforming growth factor-beta (TGFβ)/Smad3 signaling pathway-related protein expression changes were evaluated using western blot.
RESULTS: HMGA2 was upregulated in NPC cell lines and clinical specimens (P < 0.01), and HMGA2 expression correlated significantly with metastasis (P = 0.02) and disease-free survival of NPC (hazard ratio: 3.52; 95% confidence interval: 1.34-7.79; P = 0.01). In addition, following in vitro knockdown of HMGA2, the aggressiveness of cells was markedly inhibited, Vimentin and Snail level was downregulated and E-cadherin expression was upregulated. Moreover, the expression of key proteins TGFβRII and p-Smad3 of the TGFβ/Smad3 signaling pathway was inhibited by the downregulation of HMGA2.
CONCLUSION: HMGA2 might maintain EMT-induced invasion and migration through the TGFβ/Smad3 signaling pathway in NPC cell lines.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; High-mobility group protein 2; NPC

Mesh:

Substances:

Year:  2015        PMID: 26025649     DOI: 10.1016/j.bbrc.2015.05.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.

Authors:  Tao Li; Xiao-Dong Yang; Chun-Xiang Ye; Zhan-Long Shen; Yang Yang; Bo Wang; Peng Guo; Zhi-Dong Gao; Ying-Jiang Ye; Ke-Wei Jiang; Shan Wang
Journal:  Cell Cycle       Date:  2016-12-08       Impact factor: 4.534

2.  The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.

Authors:  Harpreet Kaur; Sabeen Zulfiqar Ali; Lauren Huey; Marianne Hütt-Cabezas; Isabella Taylor; Xing-Gang Mao; Melanie Weingart; Qian Chu; Fausto J Rodriguez; Charles G Eberhart; Eric H Raabe
Journal:  Cancer Lett       Date:  2016-04-18       Impact factor: 8.679

3.  Nanoscale Assembly of High-Mobility Group AT-Hook 2 Protein with DNA Replication Fork.

Authors:  Natalie Krahn; Markus Meier; Vu To; Evan P Booy; Kevin McEleney; Joe D O'Neil; Sean A McKenna; Trushar R Patel; Jörg Stetefeld
Journal:  Biophys J       Date:  2017-12-19       Impact factor: 4.033

4.  ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2.

Authors:  Li Xu; Wei-Lin Liao; Qi-Jue Lu; Chun-Guang Li; Yang Yuan; Zhi-Yun Xu; Sheng-Dong Huang; He-Zhong Chen
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

5.  Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.

Authors:  Pei-Ming Yang; Ming-Heng Wu; Chi-Chen Huang; Chun-Yu Kao; Yi-Chao Lee; Kuen-Haur Lee
Journal:  PeerJ       Date:  2016-02-11       Impact factor: 2.984

6.  HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.

Authors:  Bo Kou; Wei Liu; Xiaoshuang Tang; Qingshan Kou
Journal:  Oncol Rep       Date:  2017-11-10       Impact factor: 3.906

7.  miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.

Authors:  Zhi-Hua Ye; Ding-Wen Gui
Journal:  Mol Med Rep       Date:  2018-02-08       Impact factor: 2.952

Review 8.  Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition.

Authors:  Aristidis Moustakas; Carl-Henrik Heldin
Journal:  J Clin Med       Date:  2016-06-29       Impact factor: 4.241

9.  High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.

Authors:  Ning Na; Tujie Si; Zhengyu Huang; Bin Miao; Liangqing Hong; Heng Li; Jiang Qiu; Jianguang Qiu
Journal:  Onco Targets Ther       Date:  2016-11-22       Impact factor: 4.147

10.  Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.

Authors:  Kazutaka Ouchi; Mitsuru Miyachi; Shigeki Yagyu; Ken Kikuchi; Yasumichi Kuwahara; Kunihiko Tsuchiya; Tomoko Iehara; Hajime Hosoi
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.